Team:British Columbia/Accomplishments
From 2011.igem.org
(Difference between revisions)
(→Human Practice) |
(→Modeling Results) |
||
Line 23: | Line 23: | ||
[[File:Monoterpene Production vs Time in Pinene Synthase.jpg]] | [[File:Monoterpene Production vs Time in Pinene Synthase.jpg]] | ||
+ | |||
+ | We simulated the expansion of the MPB population from year 2011 to 2020 using the estimates obtained from the clustering analysis. For cost estimation and prediction of emergence of subpopulations, refer to our Model Methodology above. | ||
+ | |||
+ | <html><center> | ||
+ | |||
+ | |||
+ | <iframe width="480" height="360" src="http://www.youtube.com/embed/kNHwoSdRjaY" frameborder="0" allowfullscreen></iframe> | ||
+ | </br></br></div> | ||
+ | <div id="links"></center> | ||
===Human Practice=== | ===Human Practice=== |
Revision as of 00:12, 28 October 2011
Project Accomplishments
Wet Laboratory Results
1. In vitro assay production of monoterpene in bacteria
Geranyl Pyrophosphate (GPP) Assay
Alpha-beta pinene and Beta-pinene synthases were The purified enzymes were assayed in vitro with GPP and sent for GC-MS, which confirmed alpha- and beta-pinene as products.
Modeling Results
We simulated the expansion of the MPB population from year 2011 to 2020 using the estimates obtained from the clustering analysis. For cost estimation and prediction of emergence of subpopulations, refer to our Model Methodology above.
===Human Practice===
https://static.igem.org/mediawiki/2011/b/b9/Ubcigemscienceworldoutreach.jpg
===Special Considerations===